ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print January 22, 2009, 10.1183/09031936.00062708
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
33/5/1105    most recent
09031936.00062708v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Finney-Hayward, T. K.
Right arrow Articles by Donnelly, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finney-Hayward, T. K.
Right arrow Articles by Donnelly, L. E.
Eur Respir J 2009; 33:1105-1112
Copyright ©ERS Journals Ltd 2009

Leukotriene B4 release by human lung macrophages via receptor- not voltage-operated Ca2+ channels

T. K. Finney-Hayward1, P. Bahra2, S. Li2, C. T. Poll2, A. G. Nicholson3, R. E. K. Russell4, P. A. Ford1, J. Westwick2, P. S. Fenwick1, P. J. Barnes1 and L. E. Donnelly1

Depts of 1 Airways Disease and 3 Histopathology, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, 2 Novartis Institutes for BioMedical Research, Horsham, and 4 Chest Clinic, King Edward King VII Hospital, Windsor, UK.

CORRESPONDENCE: L. E. Donnelly, Airways Disease, National Heart and Lung Institute, Dovehouse St, London, SW3 6LY, UK. Fax: 44 2073518126. E-mail: l.donnelly{at}imperial.ac.uk

Keywords: Ca2+ transients, leukotriene B4, macrophage

Received: August 22, 2008
Accepted December 5, 2008

Increased numbers of macrophages and neutrophils in the lung is a key feature of chronic obstructive pulmonary disease (COPD). The major neutrophil chemotactic agent in the airways of COPD patients is leukotriene (LT)B4 and is released by macrophages. The present study examines the role and mechanism of Ca2+ in platelet-activating factor (PAF)-stimulated LTB4 release from human lung macrophages.

Macrophages were isolated from lung tissue of subjects undergoing lung resection surgery and monocyte-derived macrophages (MDM) were obtained from nonsmokers, smokers without obstruction and COPD patients. Cells were stimulated with PAF and LTB4 release and [Ca2+]i was measured.

Lung macrophages and MDM released LTB4 following stimulation with PAF (mean effective concentration: 0.08±0.06 µM (n = 5) versus 0.17±0.12 µM (n = 17), respectively). Compared with MDM, lung macrophages released approximately eight-fold more LTB4. Neither smoking nor COPD altered MDM responses. PAF-stimulated LTB4 release was abrogated by ethylene glycol tetraacetic acid suggesting a role for extracellular Ca2+. This was substantiated by using store-operated channel blockers econazole, SK&F96365 and Gd3+. However, econazole and SK&F96365 were more effective in MDM than lung macrophages. Neither LOE908 nor nifedipine could attenuate this response.

These data suggest that platelet-activating factor-stimulated leukotriene B4 release from human lung macrophages is mediated, in part, by Ca2+ influx through receptor- but not voltage-operated Ca2+ channels.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the European Respiratory Society.